|
Abstract Submission and important dates:
-EXTENDED to April 9th, 2010: Deadline for the abstract submission
CLICK HERE TO SUBMIT YOUR ABSTRACT
Abstract Format
All submitted abstracts must meet the following format:
a) All text should be in 12 point Arial font
b) Abstracts SHOULD NOT EXCEED 400 WORDS or ONE PAGE (including author & affiliation information, and references).
c) Provide the presenting author, affiliation and abstract title as follows on the top right of the abstract, bolded:
Title of Abstract: Bold Text
Presenting Author (including degree, MD, Ph.D. etc.): Bold Text
Institution/University: Regular Font, Italicize
d) List all additional authors on the bottom after the abstract text:
e.g. Full List Authors: Joe Blogs MD, University of Tumors; Jane White Ph.D., George Washington University, John Smith MD, Ph.D., Institute of Medical Research, Mary Lee, MD, Jones University
e) Where scientific abbreviations are used, please include the full wording the first time this is used and the abbreviation thereafter. Please do not include Greek or other symbols but use the longhand version of the word (e.g. alpha, beta, delta).
f) Please indicate the granting agency & mechanism whose fiscal support that made the research possible at the end of the abstract.
g) The Name of file should be labeled with the presenting author’s name as follows: Last Name, First Name
Posters
-The dimensions of all posters should be 4 ft. H X 6 ft. L
-Please note that your poster may not exceed these dimensions.
-Tacks will be available.
-All posters will be available for viewing from Monday, May 3 to Tuesday, May 4.
Please read carefully IMPORTANT NOTES below about your abstract, poster or presentation.
1. ALL abstracts accepted will be printed in a Program and Abstract Book for distribution to meeting attendees.
2. The Program and Abstract Book will be made available online at www.ctf.org at the end of April prior to the meeting. .
3. Your abstract, poster and presentation at the meeting constitute public disclosure. For more information on public disclosure as it relates to future publications & patent filings from your research, you may wish to speak with your institution’s Technology Transfer/Patenting & Licensing Office.
Please contact
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
if you have questions. This email address is being protected from spam bots, you need Javascript enabled to view it
|
